Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Fitzgerald

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Developmental Neurorehabilitation|June 25, 2014
Local visual perception bias in children with high-functioning autism spectrum disorders; do we have the whole picture?Marita Falkmer, Melissa Black, Julia Tang, et al.
Brain, Behavior, and Immunity|February 15, 2023
Age-associated deficits in social behaviour are microbiota-dependentJoana S Cruz-Pereira, Gerard M Moloney, Thomaz F S Bastiaanssen, et al.
Emergency Medicine Journal : EMJ|May 28, 2011
Interhospital variation in the RATPAC trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers)Mike Bradburn, Steve W Goodacre, Patrick Fitzgerald, et al.
The Patient|October 15, 2011
Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluationsAndrew Lloyd, Paul Hodgkins, Rahul Sasane, et al.
Zoo Biology|April 12, 2022
Conservation psychology strategies for collaborative planning and impact evaluationLily Maynard, Paige Howorth, Jaret Daniels, et al.
Current Opinion in Pediatrics|September 12, 2009
Surgical advances in the treatment of adults with congenital heart diseaseJoseph A Dearani, Constantine Mavroudis, James Quintessenza, et al.
Nature|March 4, 2011
Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosisAndrew Oberst, Christopher P Dillon, Ricardo Weinlich, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?Suzanne E Mahady, Barbara Charlton, Patrick Fitzgerald, et al.
Cell|September 2, 2022
Sublethal cytochrome c release generates drug-tolerant persister cellsHalime Kalkavan, Mark J Chen, Jeremy C Crawford, et al.
Cancer|October 1, 2008
Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 casesJames Y Chen, George Hruby, Richard A Scolyer, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Developmental Neurorehabilitation|June 25, 2014
Local visual perception bias in children with high-functioning autism spectrum disorders; do we have the whole picture?Marita Falkmer, Melissa Black, Julia Tang, et al.
Brain, Behavior, and Immunity|February 15, 2023
Age-associated deficits in social behaviour are microbiota-dependentJoana S Cruz-Pereira, Gerard M Moloney, Thomaz F S Bastiaanssen, et al.
Emergency Medicine Journal : EMJ|May 28, 2011
Interhospital variation in the RATPAC trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers)Mike Bradburn, Steve W Goodacre, Patrick Fitzgerald, et al.
The Patient|October 15, 2011
Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluationsAndrew Lloyd, Paul Hodgkins, Rahul Sasane, et al.
Zoo Biology|April 12, 2022
Conservation psychology strategies for collaborative planning and impact evaluationLily Maynard, Paige Howorth, Jaret Daniels, et al.
Current Opinion in Pediatrics|September 12, 2009
Surgical advances in the treatment of adults with congenital heart diseaseJoseph A Dearani, Constantine Mavroudis, James Quintessenza, et al.
Nature|March 4, 2011
Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosisAndrew Oberst, Christopher P Dillon, Ricardo Weinlich, et al.
Journal of Gastroenterology and Hepatology|July 3, 2010
Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?Suzanne E Mahady, Barbara Charlton, Patrick Fitzgerald, et al.
Cell|September 2, 2022
Sublethal cytochrome c release generates drug-tolerant persister cellsHalime Kalkavan, Mark J Chen, Jeremy C Crawford, et al.
Cancer|October 1, 2008
Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 casesJames Y Chen, George Hruby, Richard A Scolyer, et al.
Pageof 9